Publication | Closed Access

A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study

Phase Ii EvaluationMedicinePersistent Platinum-resistant OvarianMetronomic TherapyGynecologyFallopian TubeCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer